Back to Atlas
CTransientStandard research/education caution
CMP-0413
Supplement
Palmitoylethanolamide acute-use
Anti-inflammatory / Analgesic
Pain/inflammation symptom support
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Lipid amide
- Primary mechanism
- PPAR-alpha and mast-cell modulation
- Primary market use
- Pain/inflammation
Pharmacology
- Molecular weight (Da)
- 299.5
- Oral bioavailability
- Oral; low-moderate
- Half-life
- ~6-8 h
- Route tags
- Route-dependent / verify
- Evidence level
- Human/supplement
- Clinical status
- Supplement
- Value-for-money score
- 7 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Transient symptom control; duplicate use-case classification